DISEASE INDICATIONS: HIV/AIDS
MANUFACTURER: Gilead Sciences International Limited
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Descovy, which contains the active ingredients emtricitabine and tenofovir alafenamide, is a medication used to treat and prevent HIV infection. It is also approved for the prevention of HIV transmission in certain high-risk populations.